A/H1N1 flu: HPA advice on antipyretics contradicts NICE guideline

BMJ (Online)

Volumn 339, Issue 7715, 2009, Pages 253-

  Johnson, Gina ^a  

^a National Minor Illness Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPYRETIC AGENT; ANALGESIC AGENT;

CHILDHOOD DISEASE; DRUG USE; FEVER; HEALTH SERVICE; INFLUENZA; INFLUENZA VIRUS A H1N1; LETTER; MALARIA; PANDEMIC; PRACTICE GUIDELINE; PRIORITY JOURNAL; SYPHILIS; HUMAN;

ANALGESICS, NON-NARCOTIC; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; PRACTICE GUIDELINES AS TOPIC;

EID: 68149117569     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b3050     Document Type: Letter

References (4)

1. National Institute for Health and Clinical Excellence (NICE). Feverish illness in children. Assessment and initial management in children younger than 5 years. NICE guideline 47, 2007. www.nice.org.uk/nicemedia /pdf/ CG47QuickRefGuide.pdf
2. Schulman CI, Namias N, Doherty J, Manning RJ, Li P, Alhaddad A, et al. The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study. Surgical Infections 2005;6:369-375 doi: 10.1089/sur.2005.6.369[CrossRef][Medline] (Pubitemid 43263277)
3. Hama R. NSAIDs and flu. BMJ 2009;338:b2345. (15 June.)[Free Full Text]
4. Health Protection Agency. Summary of prescribing guidance for the treatment and prophylaxis of influenza-like illness: treatment phase, appendix five, version 1.5, 2009. www.hpa.org.uk/web/HPAwebFile/HPAweb-C/1243581475043